एपीए उद्धरण

Mohler, A., Ney, D., Gaspar, L., Damek, D., Kavanagh, B., Reddy, K., & Chen, C. (2015). QOL-16 HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN A PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM). Neuro Oncol.

शिकागो स्टाइल उद्धरण

Mohler, Alexander, Douglas Ney, Laurie Gaspar, Denise Damek, Brian Kavanagh, Krishna Reddy, और Changhu Chen. "QOL-16 HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN A PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)." Neuro Oncol 2015.

एमएलए उद्धरण

Mohler, Alexander, et al. "QOL-16 HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN A PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)." Neuro Oncol 2015.